Checked against public sources on August 5, 2026 · LookCloser does not sell or recommend supplements.
Does the marketing hold up?
FDA recall appears in this brand's history. An exact-product recall is a direct signal. A different product from the same firm is company context, not a strike against this item.
“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.
| Organic Fermented Ashwagandha (root) | 700 mg |
|---|
We read 1 lines from the package photograph. It is our transcript of the label, not the manufacturer’s panel, and it may be incomplete.
The public sources did not settle the marketing promises on this label.
Published research exists for ingredients in this formula. Whether this product’s doses match those studies could not be confirmed.
Ingredient research can support context, but it is not a trial of this exact product.
Premier Ashwagandha undergoes traditional lactic acid fermentation and has powerful postbiotics to enhance metabolic fun
Headlines first. Open evidence only when you want the source trail.
An exact-product recall is a direct signal. A different product from the same firm is company context, not a strike against this item.
This recall is not about the product on this page. Premier Research Labs LLC recalled a different product on June 15, 2022. FDA has since closed that case. The recalled item was “AloePro Dietary Supplement Made With Organic ALOE VERA LIQUID 16 FL Oz.…”
Locked evidence record →Open the full source-linked findingEvery ingredient shows its real amount — nothing is hidden in a proprietary blend.
The panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.
Locked evidence record →Open the full source-linked findingThese are evidence gaps, not strikes against the product.
Filed address
Building B, 3500 Wadley Place, Austin, TEXAS 78728, UNITED STATES
USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗
We could not match an amount on this product to a studied range for the same ingredient, so these links are ingredient background rather than a measurement of this product.
Not a score. Studies disagree with each other and change over time, so this sits beside the evidence rather than counting toward it — it is here so you can read the sources yourself.
The panel lists 700 mg of ashwagandha per serving. Studies we found used 250 mg–600 mg a day, so this sits above that range.
Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.
$0.52 per labeled serving
matching UPC/GTIN · checked Aug 5, 2026
View on Amazon ↗We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search iHerb ↗We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search Target ↗We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search Walmart ↗Only one exact price was available at build time; prices change by date, seller, and promotion.
No official brand storefront is confirmed in this record. That is neutral, but it prevents a direct brand-price, label, review, and document check.
Reference prices only · no affiliate links · every compared seller must publish the matching UPC/GTIN.
The full report shows every source, the exact unresolved question, and the documentation that would settle it.
Record built August 05, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.